Silvia Meschi

3.9k total citations
61 papers, 1.2k citations indexed

About

Silvia Meschi is a scholar working on Infectious Diseases, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Silvia Meschi has authored 61 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Infectious Diseases, 18 papers in Epidemiology and 12 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Silvia Meschi's work include SARS-CoV-2 and COVID-19 Research (26 papers), COVID-19 Clinical Research Studies (14 papers) and Viral Infections and Vectors (14 papers). Silvia Meschi is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (26 papers), COVID-19 Clinical Research Studies (14 papers) and Viral Infections and Vectors (14 papers). Silvia Meschi collaborates with scholars based in Italy, United States and Tanzania. Silvia Meschi's co-authors include Maria Rosaria Capobianchi, Giuseppe Ippolito, Concetta Castilletti, Francesca Colavita, Licia Bordi, Daniele Lapa, Antonino Di, Fabrizio Maggi, Elisabetta Andreoli and Giulia Matusali and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Journal of Clinical Microbiology.

In The Last Decade

Silvia Meschi

56 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Silvia Meschi Italy 21 771 355 270 120 110 61 1.2k
Giulia Matusali Italy 19 743 1.0× 289 0.8× 322 1.2× 190 1.6× 315 2.9× 72 1.4k
Kyle Rosenke United States 20 845 1.1× 516 1.5× 128 0.5× 250 2.1× 121 1.1× 57 1.4k
Adam J. Hume United States 19 778 1.0× 452 1.3× 114 0.4× 315 2.6× 233 2.1× 38 1.3k
Daniele Lapa Italy 19 567 0.7× 436 1.2× 96 0.4× 157 1.3× 118 1.1× 58 1.1k
Bobo Wing-Yee Mok Hong Kong 22 697 0.9× 425 1.2× 236 0.9× 451 3.8× 346 3.1× 34 1.5k
Frank Mattes United Kingdom 17 500 0.6× 694 2.0× 254 0.9× 99 0.8× 177 1.6× 23 1.3k
Henda Triki Tunisia 20 1.0k 1.3× 934 2.6× 376 1.4× 119 1.0× 117 1.1× 102 1.8k
Tabea Binger Germany 13 979 1.3× 202 0.6× 93 0.3× 103 0.9× 61 0.6× 20 1.2k
Émilie Frobert France 22 538 0.7× 1.1k 3.0× 78 0.3× 227 1.9× 197 1.8× 59 1.5k
Jira Chansaenroj Thailand 18 441 0.6× 337 0.9× 186 0.7× 201 1.7× 58 0.5× 72 942

Countries citing papers authored by Silvia Meschi

Since Specialization
Citations

This map shows the geographic impact of Silvia Meschi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvia Meschi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvia Meschi more than expected).

Fields of papers citing papers by Silvia Meschi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvia Meschi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvia Meschi. The network helps show where Silvia Meschi may publish in the future.

Co-authorship network of co-authors of Silvia Meschi

This figure shows the co-authorship network connecting the top 25 collaborators of Silvia Meschi. A scholar is included among the top collaborators of Silvia Meschi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvia Meschi. Silvia Meschi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Augello, Matteo, Valeria Bono, Roberta Rovito, et al.. (2025). Long-term immune responses to SARS-CoV-2 Omicron BA.4/5 mRNA booster in people living with HIV. Communications Medicine. 5(1). 92–92.
2.
Minosse, Claudia, Pietro Giorgio Spezia, Valentina Mazzotta, et al.. (2025). Assessing Torquetenovirus (TTV) as a Biomarker for Immune Responses to SARS-CoV-2 mRNA Vaccines in People Living with HIV and Healthy Individuals. Vaccines. 13(2). 153–153.
3.
Matusali, Giulia, Alessandra Vergori, Eleonora Cimini, et al.. (2024). Poor durability of the neutralizing response against XBB sublineages after a bivalent mRNA COVID‐19 booster dose in persons with HIV. Journal of Medical Virology. 96(4). e29598–e29598. 1 indexed citations
5.
Meschi, Silvia, et al.. (2024). Occult HBV Infection in Patients Infected by HIV or HCV: Comparison between HBV-DNA and Two Assays for HBsAg. Viruses. 16(3). 412–412. 3 indexed citations
6.
Santoro, Annapaola, Daniele Petrone, Francesca Colavita, et al.. (2023). SARS-CoV-2 Breakthrough Infections According to the Immune Response Elicited after mRNA Third Dose Vaccination in COVID-19-Naïve Hospital Personnel. Biomedicines. 11(5). 1247–1247. 4 indexed citations
7.
Montalbano, Marzia, Paola Piccolo, Raffaella Lionetti, et al.. (2023). Third dose of SARS‐CoV2 mRNA vaccination produces robust persistent cellular and humoral immune responses in liver transplant recipients. Liver International. 43(5). 1120–1125. 2 indexed citations
8.
Carissimi, Claudia, Ilaria Laudadio, Fabiola Ciccosanti, et al.. (2023). A microRNA Arising from the Negative Strand of SARS-CoV-2 Genome Targets FOS to Reduce AP-1 Activity. Non-Coding RNA. 9(3). 33–33. 2 indexed citations
9.
Minosse, Claudia, Giulia Matusali, Silvia Meschi, et al.. (2023). Torquetenovirus Loads in Peripheral Blood Predict Both the Humoral and Cell-Mediated Responses to SARS-CoV-2 Elicited by the mRNA Vaccine in Liver Transplant Recipients. Vaccines. 11(11). 1656–1656. 3 indexed citations
10.
Matusali, Giulia, Giuseppe Sberna, Silvia Meschi, et al.. (2022). Differential Dynamics of SARS-CoV-2 Binding and Functional Antibodies upon BNT162b2 Vaccine: A 6-Month Follow-Up. Viruses. 14(2). 312–312. 15 indexed citations
11.
Petrone, Linda, Andrea Picchianti Diamanti, Gian Domenico Sebastiani, et al.. (2022). Humoral and cellular responses to spike of δ SARS-CoV-2 variant in vaccinated patients with immune-mediated inflammatory diseases. International Journal of Infectious Diseases. 121. 24–30. 21 indexed citations
12.
Agrati, Chiara, Stefania Capone, Concetta Castilletti, et al.. (2021). Strong immunogenicity of heterologous prime-boost immunizations with the experimental vaccine GRAd-COV2 and BNT162b2 or ChAdOx1-nCOV19. npj Vaccines. 6(1). 131–131. 7 indexed citations
13.
Matusali, Giulia, Francesca Colavita, Daniele Lapa, et al.. (2021). SARS-CoV-2 Serum Neutralization Assay: A Traditional Tool for a Brand-New Virus. Viruses. 13(4). 655–655. 40 indexed citations
14.
Puro, Vincenzo, Concetta Castilletti, Chiara Agrati, et al.. (2021). Impact of Prior Influenza and Pneumoccocal Vaccines on Humoral and Cellular Response to SARS-CoV-2 BNT162b2 Vaccination. Vaccines. 9(6). 615–615. 13 indexed citations
15.
Colavita, Francesca, Francesco Vairo, Silvia Meschi, et al.. (2021). COVID-19 Rapid Antigen Test as Screening Strategy at Points of Entry: Experience in Lazio Region, Central Italy, August–October 2020. Biomolecules. 11(3). 425–425. 21 indexed citations
16.
Nardacci, Roberta, Francesca Colavita, Concetta Castilletti, et al.. (2021). Evidences for lipid involvement in SARS-CoV-2 cytopathogenesis. Cell Death and Disease. 12(3). 263–263. 85 indexed citations
17.
D’Offizi, Gianpiero, Chiara Agrati, Ubaldo Visco‐Comandini, et al.. (2021). Coordinated cellular and humoral immune responses after two‐dose SARS‐CoV2 mRNA vaccination in liver transplant recipients. Liver International. 42(1). 180–186. 30 indexed citations
18.
Bordi, Licia, Antonio Piralla, Eleonora Lalle, et al.. (2020). Rapid and sensitive detection of SARS-CoV-2 RNA using the Simplexa™ COVID-19 direct assay. Journal of Clinical Virology. 128. 104416–104416. 57 indexed citations
19.
Meschi, Silvia, Francesca Colavita, Licia Bordi, et al.. (2020). Performance evaluation of Abbott ARCHITECT SARS-CoV-2 IgG immunoassay in comparison with indirect immunofluorescence and virus microneutralization test. Journal of Clinical Virology. 129. 104539–104539. 61 indexed citations
20.
Valli, Maria Beatrice, Marina Selleri, Silvia Meschi, et al.. (2011). Hemagglutinin 222 variants in pandemic (H1N1) 2009 virus.. Università Politecnica delle Marche (Università Politecnica delle Marche). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026